STOCK TITAN

Bunge (NYSE: BG) director Christopher Mahoney receives 1,654-share RSU grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Mahoney Christopher reported acquisition or exercise transactions in this Form 4 filing.

Bunge Global SA director Christopher Mahoney received an equity award tied to company stock. The filing shows a grant of 1,654 shares of common stock in the form of Restricted Stock Units, which are expected to vest in full on May 20, 2027. After this award, Mahoney directly holds 8,311 shares of Bunge common stock. This appears to be a routine director compensation grant rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Mahoney Christopher
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,654 $0.00 --
Holdings After Transaction: Common Stock — 8,311 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSU award size 1,654 shares Grant of Restricted Stock Units on May 20, 2026
Post-transaction holdings 8,311 shares Common stock directly held after the grant
Grant price $0.00 per share Compensation-related RSU award, no cash purchase price
RSU vesting date May 20, 2027 RSUs expected to vest in full on this date
Restricted Stock Units ("RSUs") financial
"Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
convertible into one share financial
"One RSU is convertible into one share of Bunge common stock."
vest in full financial
"RSUs are expected to vest in full on May 20, 2027."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mahoney Christopher

(Last)(First)(Middle)
C/O BUNGE GLOBAL SA
1391 TIMBERLAKE MANOR PARKWAY

(Street)
CHESTERFIELD MISSOURI 63017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bunge Global SA [ BG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A1,654(1)A$08,311D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge common stock. RSUs are expected to vest in full on May 20, 2027.
Remarks:
/s/ Drew Yaeger, Attorney-in-Fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Bunge (BG) director Christopher Mahoney report in this Form 4?

Christopher Mahoney reported receiving an equity award linked to Bunge stock. The filing shows a grant of 1,654 Restricted Stock Units, each convertible into one share of common stock, as part of his director compensation package.

How many Bunge (BG) shares does Christopher Mahoney hold after this transaction?

After the reported grant, Christopher Mahoney directly holds 8,311 shares of Bunge common stock. This total includes the newly awarded 1,654 Restricted Stock Units, which are structured to convert into shares upon vesting.

What type of equity award did Christopher Mahoney receive from Bunge (BG)?

Mahoney received an award of Restricted Stock Units, or RSUs. Each RSU is convertible into one share of Bunge common stock, providing equity-based compensation that aligns his interests with long-term shareholder value.

When do Christopher Mahoney’s Bunge (BG) RSUs from this grant vest?

The Restricted Stock Units granted to Mahoney are expected to vest in full on May 20, 2027. Vesting means the RSUs convert into shares of common stock that he can own outright, subject to any applicable company policies.

Was this Bunge (BG) Form 4 an open-market stock purchase or sale?

No, the Form 4 reflects a grant or award acquisition rather than an open-market trade. The transaction code indicates a compensation-related grant of 1,654 Restricted Stock Units at no cash purchase price.